Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 4 of 4
Tablet
Teneligliptin Hydrobromlde Hydrate 20MG Tablets (film coated) is a tablet formulated with Teneligliptin Hydrobromlde Hydrate 20MG ( ). The listed active ingredient profile is Teneligliptin Hydrobromlde Hydrate, placing the product in the oral antidiabetic
Tablet
Teneligliptin Tablets IP 20mg (Film coated) is a tablet formulated with Teneligliptin IP 20mg ( ). The listed active ingredient profile is Teneligliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral gluc
Tablet
Tenellgliptin 20mg + Metformin Hydrochloride (Extended Release) 500mg Tablets (Uncoated blayered) is a tablet formulated with Tenellgliptin 20mg + Metformin Hydrochloride ( ) 500mg ( blayered). The listed active ingredient profile is Tenellgliptin; Metfor
Tablet
Tolvaptan 15mg Tablets (film coated) is a tablet formulated with Tolvaptan 15mg ( ). The listed active ingredient profile is Tolvaptan, placing the product in the vasopressin antagonist / aquaretic category. The active ingredient alters renal free-water h
Tablet
Tolvaptan 15Smg Tablet (film coated) is a tablet formulated with Tolvaptan 15Smg ( ). The listed active ingredient profile is Tolvaptan 15Smg, placing the product in the vasopressin antagonist / aquaretic category. The active ingredient alters renal free-
Tablet
Trimetazidine Hydrochloride 20mg Tab. (Film Coated) is a tablet formulated with Trimetazidine Hydrochloride 20mg . ( ). The listed active ingredient profile is Trimetazidine Hydrochloride, placing the product in the antianginal / cardiovascular category.
Tablet
Valsartan 160mg + Hydrochlorothiazide 12.5mg Tab. (Filrm coated) is a tablet formulated with Valsartan 160mg + Hydrochlorothiazide 12.5mg . (Filrm coated). The listed active ingredient profile is Valsartan; Hydrochlorothiazide, placing the product in the
Tablet
Vildagliptin 50 mg + Metformin HCI 1000 mg Tablets is a tablet formulated with Vildagliptin 50 mg + Metformin HCI 1000 mg. The listed active ingredient profile is Vildagliptin; Metformin HCI, placing the product in the oral antidiabetic category. The form
Tablet
Vildagliptin 50mg + Metformin Hydrochlortde 500mg Tablets (Film coated) is a tablet formulated with Vildagliptin 50mg + Metformin Hydrochlortde 500mg ( ). The listed active ingredient profile is Vildagliptin; Metformin Hydrochlortde, placing the product i
Tablet
Vildagliptin 50MG Tablet (Uncoated Tablet) is a tablet formulated with Vildagliptin 50MG ( ). The listed active ingredient profile is Vildagliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lo
Tablet
Voglibose 0.2mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose; Metformin, placing the product in the oral antidiabetic category. The formulation con
Tablet
Voglibose 0.2mg Tab. (Uncoated) is a tablet formulated with Voglibose 0.2mg . ( ). The listed active ingredient profile is Voglibose, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicin
Bilayered Tablet
Voglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg, Glimepiride Img + Metformin Hydrochloride 500mg ( ). The listed active ingredient profile is Voglibose; Gl
Bilayered Tablet
Voglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Voglibose 0.2mg. Glimepiide 2mg + Metformin Hydrochloide 500mg ( ). The listed active ingredient profile is Voglibose . Glime
Tablet
Voglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg (Uncoated Tab) is a tablet formulated with Voglibose lP 0.3 mg + Glimepride IP1 mg + Metformin Hcl IP SR 500 mg ( ). The listed active ingredient profile is Voglibose lP; Glimepride IP1
Tablet
Voglibose O.3mg + Metformin 500mg Tab. (Uncoated) is a tablet formulated with Voglibose O.3mg + Metformin 500mg . ( ). The listed active ingredient profile is Voglibose O; Metformin, placing the product in the oral antidiabetic category. The formulation c
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
